Category: Wall Street BeatSyndicate content

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.

Medtronic updates on $43B Covidien deal financing

Boston Scientific, Bard CEOs cool on consolidation

October 23, 2014 by Brad Perriello

The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.

Boston Scientific, Bard CEOs cool on consolidation

Five major factors will determine the future of the medical device industry | Medtech Wall Street news for the week of October 20, 2014

October 23, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: 5 factors affecting the future of medtech; Medtech VC deals post double-digit increases in Q3; Breast implant maker Sientra sets IPO range; GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare; GI Dynamics proposes 1-for-10 reverse stock split

5 factors affecting the future of medtech

October 20, 2014 by Brad Perriello

5 factors affecting the future of medtech

EQT frontrunner for Siemens hearing-aids business: sources

October 22, 2014 by MassDevice

Siemens is in advanced talks to sell its hearing-aids business to private equity shop EQT, unnamed sources tell Reuters.

EQT frontrunner for Siemens hearing-aids business: sources

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

October 22, 2014 by MassDevice

Abbott says it will go ahead with its plan to deal its generic pharmaceuticals line to Mylan for $5.3 billion and reports 3rd-quarter sales in line with expectations.

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

Covidien, Medtronic shares jump on affirmation of $43B merger

October 22, 2014 by Brad Perriello

Shares of Medtronic and Covidien gain after Medtronic affirms its $43 billion acquisition plans, saying it now expects to close the deal for Covidien late this year or early in 2015.

Covidien, Medtronic shares jump on affirmation of $43B merger

GI Dynamics proposes 1-for-10 reverse stock split

October 21, 2014 by Val Kennedy

GI Dynamics shareholders are slated to vote on whether to approve a 1-for-10 reverse stock split in an effort to raise the company's lagging share price.

GI Dynamics proposes 1-for-10 reverse stock split
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp